The Journal of Pathology · 1993 · 94 citations · 14 references
Life SciencesDermatologyImmunologyAutoimmunityImmunopathologyMolecular ImmunologyAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune Skin DiseasesImmunopathology Of SkinMelanocytic LesionsT Cell ActivationAutoimmune Skin PathologyImmune Response RegulationIntercellular Adhesion Molecule 1Melanoma-associated AntigensMhc Antigen PresentationMhc Class Ii MoleculesPsoriasis ImmunopathologyT-cell Mediated Skin Disease
The relationship between damage to cutaneous melanocytes and antimelanocyte autoimmunity in vitiligo is unclear. We have demonstrated abnormal expression of MHC class II molecules by perilesional melanocytes in 13/21 patients with vitiligo and a six-fold increase in the number expressing the intercellular adhesion molecule ICAM-1. These molecules have important roles in normal antigen presentation and activation of helper T lymphocytes, and their expression by melanocytes may contribute to the abnormal immune response in vitiligo. MHC class II is not expressed by melanocytes in psoriasis and is unlikely to be induced in vitiligo by cytokines released from activated non-melanocyte-specific T lymphocytes.
14
Dermatology in General Medicine.
Annals of Internal Medicine · 1988 · 1.2K citations
Medicine, Dermatology, Microbiology +17
Epidermal T lymphocytes and HLA-DR expression in psoriasis
Barbara S. Baker, A.F. SWAIN, Lionel Fry et al. · British Journal of Dermatology · 2006 · 293 citations
Medicine, Dermatology, Immunology +16
Alan K. Foulis, M. A. Farquharson, Rebecca E. Hardman · Diabetologia · 1987 · 249 citations · Full text